Moshe Alafi, 10% Owner at Intra-Cellular Therapies, Inc. (ITCI), bought 12,200 shares at $15.23 ($187K) on 2014-11-12, disclosed to the SEC on 2014-11-13.
Open-market purchase of $187k ITCI by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.55 | 5,000 | $78K | 41.5% |
| 2 | $15.23 | 5,000 | $76K | 40.7% |
| 3 | $15.12 | 2,200 | $33K | 17.8% |
| Total | $15.34 avg | 12,200 | $187K | 100% |
| Filing → |
| ITCI | BUY | 2016-11-17 | $493K | — | Filing → |
| ITCI | BUY | 2014-12-03 | $21K | — | Filing → |
| ITCI | BUY | 2014-11-28 | $516K | — | Filing → |